Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology
Open Access
- 1 January 2006
- journal article
- Published by Scientific Scholar in Cytojournal
- Vol. 3 (1) , 18
Abstract
Urine cytology has a critical role in evaluation for bladder carcinoma. Due to the low sensitivity of this technique, ancillary modalities such as the detection of markers of malignancy by immunochemistry are desirable. Promising factors in this context are components of the human telomerase enzyme complex. Telomerase repairs and extend telomeres, which when eroded beyond a critical limit trigger a senescence checkpoint. Accordingly, while absent in normal somatic cells, telomerase activity has been detected in the great majority of malignant tumor specimens tested, and so has potential value for the recognition of malignant cells in clinical specimens. In this study, we investigated whether the immunohistochemical detection of the catalytic subunit of telomerase (hTERT) can aid cytology in the diagnosis of bladder lesions. Findings from the retrospective evaluation of over 100 cell blocks, including urine sediments from confirmed malignant and benign conditions, were compared with routine urine cytology data. The presence of hTERT protein was indicative of the transformation of urothelia to a malignant phenotype. Nucleolar hTERT was expressed in 27 (93%) of 29 samples obtained from patients with confirmed primary bladder cancer. Conversely, hTERT was detectable in only 3 (0.8%) of 39 samples from benign conditions. The hTERT assay showed higher diagnostic sensitivity (84.8%) than published urine cytology data (~65%) for confirmed bladder carcinoma, however, the hTERT assay was less specific than cytology (65.2% vs. ~95% respectively). As a highly sensitive marker, immunohistochemical hTERT detection in urine sediments represents a reliable adjunct to cytology in the accurate diagnosis of urothelial neoplasms.Keywords
This publication has 31 references indexed in Scilit:
- hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin‐embedded tissueJournal of Cutaneous Pathology, 2005
- Functional analysis of the pseudoknot structure in human telomerase RNAProceedings of the National Academy of Sciences, 2005
- Biochemical Characterization of DNA Damage Checkpoint Complexes: Clamp Loader and Clamp Complexes with Specificity for 5′ Recessed DNAPLOS Biology, 2003
- Telomerase reverse transcriptase subunit immunoreactivityCancer, 2002
- Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumorsUrology, 2000
- [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].1998
- Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activityCancer, 1998
- Telomerase activity and its inhibition in benign and malignant breast lesionsThe Journal of Pathology, 1997
- Semiquantitative Detection of Abnormal CD44 Transcripts in Colon Carcinomas by Reverse Transcription-Polymerase Chain Reaction Enzyme-linked Immunosorbant Assay (RT-PCR ELISA).1996
- Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: A comparative studyDiagnostic Cytopathology, 1995